Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 11—November 2002
THEME ISSUE
Tuberculosis Genotyping

Tuberculosis Genotyping Network, United States

Identifying the Sources of Tuberculosis in Young Children: A Multistate Investigation

Sumi J. Sun*Comments to Author , Diane E. Bennett†, Jennifer Flood*, Ann M. Loeffler*, Steve Kammerer†, and Barbara A. Ellis†
Author affiliations: *California Department of Health Services, Berkeley, California, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Table 3

Demographic, clinical, and risk characteristics of 53 source patients with tuberculosis (TB) identified from public health investigationsa

Source patient characteristics No. (%)
Age group, yrs
15–24 11 (21)
25–44 28 (53)
45–64 10 (19)
65+ 4 (8)
Female 24 (45)
Race or ethnicity
Black, non-Hispanic 22 (42)
Hispanic 24 (45)
Asian 5 (9)
Native American or Alaskan Native 2 (4)
Foreign-bornb 27 (51)
Bacteriologic results, sputum
Smear positive/culture positive 42 (79)
Smear positive/culture negative 1 (2)
Smear negative/culture positive 8 (15)
Smear not done/culture not done 2 (4)
Cavitary chest radiographc 33 (63)
Provider type
Health department 31 (58)
Private provider 11 (11)
Both 11 (11)
Directly observed therapyd 47 (71)
Previous diagnosis of TB 5 (9)
Drug-resistant isolatee 5 (9)

aThree source patients were identified as the source of infection for more than one culture-confirmed patient who was <5 years of age in the sentinel study population; two source patients transmitted to two children, and one transmitted to three children.
bCountry of origin was Mexico for 14 (26%) of the foreign-born patients.
cResults unknown for one patient.
dCompared to patients on self-administered therapy.
eDrug resistance on initial testing of isolate; resistance to at least one of the following: isoniazid, rifampin, ethambutol, pyrazinamide, streptomycin, and ethionamide. Testing results for one or more drugs could have been unknown or not done. Excludes one source patient for whom drug susceptibility testing was not done.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO